Annotation Detail for RPTOR

Basic Information
Top
| Pathway ID | Pathway Name |
|---|
| hsa04910 | Insulin signaling pathway |
| hsa04150 | mTOR signaling pathway |
| Pathway ID | Pathway Name |
|---|
| Signaling by Insulin receptor |
| Pathway ID | Pathway Name |
|---|
| 200032 | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 200080 | mTOR signaling pathway |
| 200061 | LKB1 signaling events |
| Pathway ID | Pathway Name |
|---|
| 500865 | mTOR signalling |
| 500921 | S6K1-mediated signalling |
| 500502 | Regulation of AMPK activity via LKB1 |
| Desease ID | Desease Name |
|---|
| 2052 | Infection |
| 2176 | Tuberous sclerosis |
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of RPTOR mRNA | increases expression | 18175754
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.66 | 15894690 |
| MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.30 | 16285004 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
2.39 | 15131321 |
| MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.60 | 14714311 |
| MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.76 | 14737004 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.32 | 18760546 |